Author

A. Rafiei

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Assay:structural biology· 1

Frequent Co-Authors

A. Sali· 1 shared D. A. Crowder· 1 shared D. C. Schriemer· 1 shared D. J. Saltzberg· 1 shared G. Brouhard· 1 shared L. Lee· 1 shared M. Yazdani· 1 shared R. Valadan· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Sali

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Doublecortin engages the microtubule lattice through a cooperative binding mode involving its C- terminal domain

A. Rafiei, L. Lee, D. A. Crowder, D. J. Saltzberg, A. Sali, G. Brouhard, D. C. Schriemer

This study reveals how doublecortin binds to microtubules through a cooperative mechanism involving its C-terminal domain and C-tails, with implications for neurological disorders.

bioRxiv · Feb 17, 2021Biochemistry

Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: An in silico analysis

Z. Yazdani, A. Rafiei, M. Yazdani, R. Valadan

This paper designs a multi-epitope peptide vaccine against SARS-CoV-2 using in silico methods and shows it has immunogenic properties and can interact with TLR3, 5, and 8.

bioRxiv · Apr 20, 2020Immunology